PH18646A - Novel topically administrable pharmaceutical composition - Google Patents

Novel topically administrable pharmaceutical composition

Info

Publication number
PH18646A
PH18646A PH29667A PH29667A PH18646A PH 18646 A PH18646 A PH 18646A PH 29667 A PH29667 A PH 29667A PH 29667 A PH29667 A PH 29667A PH 18646 A PH18646 A PH 18646A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
topically administrable
administrable pharmaceutical
novel topically
novel
Prior art date
Application number
PH29667A
Other languages
English (en)
Inventor
Henning Asche
Heidi Affolter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4301192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH18646(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH18646A publication Critical patent/PH18646A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH29667A 1982-10-07 1983-10-06 Novel topically administrable pharmaceutical composition PH18646A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH589882A CH655656B (pt) 1982-10-07 1982-10-07

Publications (1)

Publication Number Publication Date
PH18646A true PH18646A (en) 1985-08-23

Family

ID=4301192

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29667A PH18646A (en) 1982-10-07 1983-10-06 Novel topically administrable pharmaceutical composition

Country Status (29)

Country Link
US (1) US4917886A (pt)
JP (1) JPS5989621A (pt)
KR (1) KR890000493B1 (pt)
AT (1) AT381638B (pt)
AU (1) AU567890B2 (pt)
BE (1) BE897934A (pt)
CA (1) CA1228812A (pt)
CH (1) CH655656B (pt)
DD (1) DD212897A5 (pt)
DE (1) DE3336047C2 (pt)
DK (1) DK160913C (pt)
DO (1) DOP1990004770A (pt)
ES (1) ES8503944A1 (pt)
FI (1) FI82185C (pt)
FR (1) FR2540726B1 (pt)
GB (1) GB2128087B (pt)
GR (1) GR79660B (pt)
HK (1) HK88590A (pt)
HU (1) HU190168B (pt)
IE (1) IE56023B1 (pt)
IL (1) IL69925A (pt)
IT (1) IT1174791B (pt)
LU (1) LU85030A1 (pt)
NL (1) NL193419C (pt)
NO (1) NO833645L (pt)
NZ (1) NZ205882A (pt)
PH (1) PH18646A (pt)
PT (1) PT77459B (pt)
SE (1) SE455835B (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
JP2557657B2 (ja) * 1987-08-28 1996-11-27 エスエス製薬株式会社 経皮吸収促進基剤組成物
NZ228431A (en) * 1988-03-21 1991-08-27 Daratech Pty Ltd Teat dip composition comprising a c16 to c20 fatty acid and a surfactant
US5438076A (en) * 1988-05-03 1995-08-01 Perio Products, Ltd. Liquid polymer composition, and method of use
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
AU642899B2 (en) * 1989-08-18 1993-11-04 Hisamitsu Pharmaceutical Co., Inc. Ketotifen preparation for external use
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5071644A (en) * 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
ATE121724T1 (de) * 1991-02-07 1995-05-15 Heumann Pharma Gmbh & Co Neue salze der 2-(2,6-dichloranilino)- phenylessigsäure, verfahren zu ihrer herstellung und ihre verwendung für topisch anwendbare pharmazeutische zubereitungen.
EP0592569A1 (en) * 1991-07-03 1994-04-20 Sano Corporation Composition and method for transdermal delivery of diclofenac
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
WO2001006993A1 (fr) * 1999-07-27 2001-02-01 Shiseido Company, Ltd. Composition d'emulsion huile dans l'eau
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
EP1328278A4 (en) 2000-09-26 2004-06-16 Univ Temple ANALGETIC AND GLUCOSAMINE COMPOSITIONS
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030017133A1 (en) * 2001-06-15 2003-01-23 Wyeth (Formerly American Home Products Corporation) Mucoadhesive composition
US20040028744A1 (en) * 2002-06-17 2004-02-12 Sauwaluxana Tongaree Mucoadhesive composition
AR041021A1 (es) 2002-08-22 2005-04-27 Novartis Consumer Health Sa Composicion topica
EP1588697A1 (en) * 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsion gel for topical application of pharmaceuticals
EP1863858A1 (de) * 2005-03-18 2007-12-12 Basf Aktiengesellschaft Kationische polymere als verdicker für wässrige und alkoholische zusammensetzungen
ATE429255T1 (de) 2005-03-24 2009-05-15 Nolabs Ab Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
US8673960B2 (en) * 2005-10-17 2014-03-18 Kowa Co., Ltd. External liquid preparation containing indomethacin
ATE510861T1 (de) 2006-09-21 2011-06-15 Basf Se Kationische polymere als verdicker für wässrige und alkoholische zusammensetzungen
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US7943668B2 (en) * 2008-03-03 2011-05-17 Altergon S.A. Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
AU2009319167A1 (en) * 2008-11-28 2010-06-03 Lectio Pharmaentwicklungs-Und Verwertungs Gmbh Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
SI2405892T1 (sl) * 2009-03-12 2013-06-28 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Farmacevtska formulacija, ki obsega ketoprofen in polioksialkilenski ester hidroksimaščobne kisline
GB0921686D0 (en) * 2009-12-11 2010-01-27 Reckitt Benckiser Healthcare I Topical formulation
WO2011076401A1 (de) * 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
ES2402289B1 (es) * 2011-10-04 2014-03-04 Eduardo COS ALFONSO Composición farmacéutica para el tratamiento de la tendinitis y/o bursitis calcificada.
PT2735309T (pt) 2012-11-27 2016-09-26 Cos Alfonso Eduardo Composição farmacêutica para o tratamento da tendinite calcificada e/ou da bursite calcificada
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
JP6513667B2 (ja) 2013-08-08 2019-05-15 ノヴァン，インコーポレイテッド 局所用組成物およびそれを使用する方法
CN105813617B (zh) * 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
RU2702898C2 (ru) * 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
JP6921493B2 (ja) * 2015-10-30 2021-08-18 小林製薬株式会社 水中油型乳化組成物
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
EP4223280A1 (en) 2022-02-02 2023-08-09 GSK Consumer Healthcare SARL Diclofenac formulations
EP4342450A1 (en) 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic topical diclofenac formulations
EP4342449A1 (en) 2022-09-21 2024-03-27 Haleon CH SARL Hydroalcoholic single phase gel compositions for topical delivery of diclofenac

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE626627A (pt) * 1962-04-26
GB1261881A (en) * 1967-12-04 1972-01-26 Ethichem Ltd Improvements in or relating to pharmaceutical compositions comprising witch hazel
US3629412A (en) * 1969-09-19 1971-12-21 Merck & Co Inc Topical anti-inflammatory agent
DK135267A (pt) * 1971-02-25
CA938555A (en) * 1971-02-26 1973-12-18 W. Hughes Donald Veterinary ointment composition
JPS475827A (pt) * 1971-08-27 1972-03-29
DE2350315C2 (de) * 1973-10-06 1984-01-12 Johnson & Johnson GmbH, 4000 Düsseldorf Pharmazeutische und kosmetische Präparate zur äußerlichen Anwendung
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
IN142640B (pt) * 1975-01-17 1977-08-06 Johnson & Johnson
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2755224A1 (de) * 1976-12-15 1978-07-13 Procter & Gamble Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung
US4120166A (en) * 1977-03-25 1978-10-17 Exxon Production Research Company Cement monitoring method
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
US4525347A (en) * 1978-06-17 1985-06-25 Kowa Company Limited Antiinflammatory analgesic gelled ointment
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
DE2843901A1 (de) * 1978-10-07 1980-04-24 Basf Ag Mittel, enthaltend all-e- oder 13-z-7, 8-dehydro-retinsaeure
JPS5927478B2 (ja) * 1979-07-06 1984-07-05 富士空調工業株式会社 エルボの製造方法
JPS5651410A (en) * 1979-10-01 1981-05-09 Sumitomo Chem Co Ltd Ointment
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
JPS57126414A (en) * 1981-01-28 1982-08-06 Sumitomo Chem Co Ltd Ointment
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
US4807824A (en) * 1988-06-27 1989-02-28 James River Ii, Inc. Paper roll towel dispenser

Also Published As

Publication number Publication date
IE56023B1 (en) 1991-03-27
KR840006440A (ko) 1984-11-30
AU567890B2 (en) 1987-12-10
FI833568A (fi) 1984-04-08
GB2128087A (en) 1984-04-26
HK88590A (en) 1990-11-02
DOP1990004770A (es) 1996-01-08
GR79660B (pt) 1984-10-31
GB2128087B (en) 1986-09-10
DE3336047A1 (de) 1984-04-12
SE8305316D0 (sv) 1983-09-29
FI82185B (fi) 1990-10-31
FI833568A0 (fi) 1983-10-03
JPH0568444B2 (pt) 1993-09-29
AT381638B (de) 1986-11-10
DK460283D0 (da) 1983-10-06
SE455835B (sv) 1988-08-15
DE3336047C2 (de) 1994-03-03
FR2540726B1 (fr) 1988-05-27
LU85030A1 (de) 1984-05-10
ES526290A0 (es) 1985-04-01
CA1228812A (en) 1987-11-03
US4917886A (en) 1990-04-17
GB8326565D0 (en) 1983-11-02
PT77459A (en) 1983-11-01
KR890000493B1 (ko) 1989-03-20
ATA354683A (de) 1986-04-15
DK460283A (da) 1984-04-08
NO833645L (no) 1984-04-09
NL8303412A (nl) 1984-05-01
DK160913C (da) 1991-10-21
AU1994783A (en) 1984-04-12
IT8349109A0 (it) 1983-10-05
IE832356L (en) 1984-04-07
SE8305316L (sv) 1984-04-08
NL193419C (nl) 1999-10-04
IL69925A (en) 1988-04-29
FI82185C (fi) 1991-02-11
HU190168B (en) 1986-08-28
PT77459B (en) 1986-06-11
FR2540726A1 (fr) 1984-08-17
NZ205882A (en) 1986-11-12
NL193419B (nl) 1999-06-01
IT1174791B (it) 1987-07-01
JPS5989621A (ja) 1984-05-23
ES8503944A1 (es) 1985-04-01
CH655656B (pt) 1986-05-15
DK160913B (da) 1991-05-06
BE897934A (fr) 1984-04-06
DD212897A5 (de) 1984-08-29

Similar Documents

Publication Publication Date Title
PH18646A (en) Novel topically administrable pharmaceutical composition
HK16090A (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
AU3298184A (en) Topically administrable pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8324487D0 (en) Topically administrable pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8324488D0 (en) Topically administrable pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions
GB8314540D0 (en) Pharmaceutical composition
GB8329391D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12